Issue 11/2004
Content (14 Articles)
Both soluble and membrane-bound forms of Flt3 ligand enhance tumor immunity following “suicide” gene therapy in a murine colon carcinoma model
Abdul-Razzak Alsheikhly, Jehad Zweiri, Alice J. Walmesley, Alastair J. M. Watson, Stephen E. Christmas
Immunotherapy with bovine aortic endothelial cells in subcutaneous and intracerebral glioma models in rats: effects on survival time, tumor growth, and tumor neovascularization
E. Corsini, M. Gelati, C. Calatozzolo, G. Alessandri, S. Frigerio, M. De Francesco, C. Poiesi, E. Parati, D. Croci, A. Boiardi, A. Salmaggi
Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell–based cancer vaccination
Joanna Galea-Lauri, James W. Wells, David Darling, Phillip Harrison, Farzin Farzaneh
Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells
A. R. Dadabayev, M. H. Sandel, A. G. Menon, H. Morreau, C. J. M. Melief, R. Offringa, S. H. van der Burg, C. Janssen-van. Rhijn, N. G. Ensink, R. A. E. M. Tollenaar, C. J. H. van de Velde, P. J. K. Kuppen
Anti-idiotype responses abrogate anti-CD4–induced tolerance to a tumor-specific antigen and promote systemic tumor immunity
Ronald C. Kennedy, Michael H. Shearer, Devin B. Lowe, Cynthia A. Jumper, Maurizio Chiriva-Internati, Robert K. Bright
Immunohistochemical characterisation of the monoclonal antibody BLCA-38 for the detection of prostate cancer
P. J. Russell, K. T. Ow, P. N. Tam, J. Juarez, E. A. Kingsley, C. F. Qu, Y. Li, P. J. Cozzi, R. Martiniello-Wilks
Virosomes as new carrier system for cancer vaccines
Ruth Schwaninger, Ernst Waelti, Paul Zajac, Antoinette Wetterwald, Dominique Mueller, Claude D. Gimmi
Dendritic cells reduce number and function of CD4+CD25+ cells in cytokine-induced killer cells derived from patients with pancreatic carcinoma
Jan Schmidt, Sven Eisold, Markus W. Büchler, Angela Märten
Generation of human tumor-specific CTLs in HLA-A2.1–transgenic mice using unfractionated peptides from eluates of human primary breast and ovarian tumors
Angelos D. Gritzapis, Nectaria N. Sotiriadou, Michael Papamichail, Constantin N. Baxevanis
CRM197 (nontoxic diphtheria toxin): effects on advanced cancer patients
Silvio Buzzi, Diego Rubboli, Giorgio Buzzi, Anna Maria Buzzi, Claudio Morisi, Flavio Pironi
Lower percentages of monocytes with CD80, CD86 and HLA-DR molecule expression in pediatric cancer
Wlodzimierz Luczynski, Anna Stasiak-Barmuta, Maryna Krawczuk-Rybak
Altered surface expression patterns of circulating monocytes in cancer patients: impaired capacity of T-cell stimulation?
Selma Ugurel, Monika Lindemann, Dirk Schadendorf, Hans Grosse-Wilde
Cancer gene therapy: new horizons in the East
Farzin Farzaneh, Nagy Habib, Peter Walden